Cancer predisposition syndromes in children

The aim of the study was to assess the prevalence of cancer predisposition syndromes among children with cancer in Moscow Region (MR).   The data on patients were retrieved from the database of Childhood Population-based Cancer Registry of MR. 35 (3.0 %) children with cancer predisposition syndromes...

Full description

Bibliographic Details
Main Authors: D. Yu. Kachanov, R. T. Abdullaev, T. V. Shamanskaya, Ye. V. Inyushkina, K. V. Dobrenkov, R. F. Savkova, S. R. Varfolomeeva
Format: Article
Language:Russian
Published: ABV-press 2022-11-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/743
_version_ 1826557065585229824
author D. Yu. Kachanov
R. T. Abdullaev
T. V. Shamanskaya
Ye. V. Inyushkina
K. V. Dobrenkov
R. F. Savkova
S. R. Varfolomeeva
author_facet D. Yu. Kachanov
R. T. Abdullaev
T. V. Shamanskaya
Ye. V. Inyushkina
K. V. Dobrenkov
R. F. Savkova
S. R. Varfolomeeva
author_sort D. Yu. Kachanov
collection DOAJ
description The aim of the study was to assess the prevalence of cancer predisposition syndromes among children with cancer in Moscow Region (MR).   The data on patients were retrieved from the database of Childhood Population-based Cancer Registry of MR. 35 (3.0 %) children with cancer predisposition syndromes were revealed among 1173 registered from 2000 till February 2010. The most prevalent syndromes were hereditary retinoblastoma (RB) – 9 (25.7 %), Down syndrome – 8 (22.8 %) and neurofibromatosis type 1–8 (22.8 %). Genetic syndromes were observed in patients with retinoblastoma – 31 %, germ-cell tumors – 6.8 % and soft tissue sarcomas (STS) – 4.5 %. The increased risk of development of leukemia in patients with Down syndrome was observed. The relative risk (RR) of 15.0 (95 % CI 1.9–333.1) for leukemia and 57.1 (95 % CI 9.3–1398.0) for AML was observed. The association of neurofibromatosis type 1 with the development of tumors of central nervous system and soft tissue sarcomas was proved. The RR was 62.5 (95 % CI 8.1–1388.6) for CNS tumors and 150,0 (95 % CI 26.9–3480.9) for STS.
first_indexed 2024-04-09T20:23:51Z
format Article
id doaj.art-02d9d9d97f244888a36e09149ac62ccc
institution Directory Open Access Journal
issn 1818-8346
2413-4023
language Russian
last_indexed 2025-03-14T08:22:40Z
publishDate 2022-11-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj.art-02d9d9d97f244888a36e09149ac62ccc2025-03-02T13:07:15ZrusABV-pressОнкогематология1818-83462413-40232022-11-01032935621Cancer predisposition syndromes in childrenD. Yu. Kachanov0R. T. Abdullaev1T. V. Shamanskaya2Ye. V. Inyushkina3K. V. Dobrenkov4R. F. Savkova5S. R. Varfolomeeva6Federal research center of pediatric hematology, oncology and immunology; Moscow Regional Oncological HospitalFederal research center of pediatric hematology, oncology and immunology; Scientific and Applied Center for the Treatment of Children with Craniofacial and Neurological DisordersFederal research center of pediatric hematology, oncology and immunologyFederal research center of pediatric hematology, oncology and immunology; Moscow Regional Oncological HospitalFederal research center of pediatric hematology, oncology and immunologyMoscow Regional Oncological HospitalFederal research center of pediatric hematology, oncology and immunologyThe aim of the study was to assess the prevalence of cancer predisposition syndromes among children with cancer in Moscow Region (MR).   The data on patients were retrieved from the database of Childhood Population-based Cancer Registry of MR. 35 (3.0 %) children with cancer predisposition syndromes were revealed among 1173 registered from 2000 till February 2010. The most prevalent syndromes were hereditary retinoblastoma (RB) – 9 (25.7 %), Down syndrome – 8 (22.8 %) and neurofibromatosis type 1–8 (22.8 %). Genetic syndromes were observed in patients with retinoblastoma – 31 %, germ-cell tumors – 6.8 % and soft tissue sarcomas (STS) – 4.5 %. The increased risk of development of leukemia in patients with Down syndrome was observed. The relative risk (RR) of 15.0 (95 % CI 1.9–333.1) for leukemia and 57.1 (95 % CI 9.3–1398.0) for AML was observed. The association of neurofibromatosis type 1 with the development of tumors of central nervous system and soft tissue sarcomas was proved. The RR was 62.5 (95 % CI 8.1–1388.6) for CNS tumors and 150,0 (95 % CI 26.9–3480.9) for STS.https://oncohematology.abvpress.ru/ongm/article/view/743childrencancercancer predisposition syndromescancer registry
spellingShingle D. Yu. Kachanov
R. T. Abdullaev
T. V. Shamanskaya
Ye. V. Inyushkina
K. V. Dobrenkov
R. F. Savkova
S. R. Varfolomeeva
Cancer predisposition syndromes in children
Онкогематология
children
cancer
cancer predisposition syndromes
cancer registry
title Cancer predisposition syndromes in children
title_full Cancer predisposition syndromes in children
title_fullStr Cancer predisposition syndromes in children
title_full_unstemmed Cancer predisposition syndromes in children
title_short Cancer predisposition syndromes in children
title_sort cancer predisposition syndromes in children
topic children
cancer
cancer predisposition syndromes
cancer registry
url https://oncohematology.abvpress.ru/ongm/article/view/743
work_keys_str_mv AT dyukachanov cancerpredispositionsyndromesinchildren
AT rtabdullaev cancerpredispositionsyndromesinchildren
AT tvshamanskaya cancerpredispositionsyndromesinchildren
AT yevinyushkina cancerpredispositionsyndromesinchildren
AT kvdobrenkov cancerpredispositionsyndromesinchildren
AT rfsavkova cancerpredispositionsyndromesinchildren
AT srvarfolomeeva cancerpredispositionsyndromesinchildren